Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D - 4T Study
- Conditions
- Type1diabetes
- Interventions
- Behavioral: 4T Education and Care
- Registration Number
- NCT04336969
- Lead Sponsor
- Stanford University
- Brief Summary
The 4Ts program encompasses: Teamwork, Targets, Technology, and Tight Control. These methods will help patients better manage their condition of Type 1 Diabetes with improved patient reported outcomes.
- Detailed Description
The goal of the 4T study is to implement proven methods and emerging diabetes technology into investigator's clinical practice to sustain tight glucose control from the onset of type 1 diabetes (T1D) and optimize patient reported and psychosocial outcomes. The investigators will define a program (4T - Teamwork, Targets, Technology, and Tight Control) translatable to Pediatric Diabetes clinics in the United States that reduces HbA1c and T1D burden and improves patient well-being.
Study Design: This is a prospective, open-label, pragmatic research study. Two related studies will be performed. In Study 2, a cohort of new onsets (160+) receiving the 4T new onset intervention designed to decrease the rise in HbA1c seen from 4 to 12 months but following a tapered remote monitoring schedule will be compared to internal (4T Pilot and 4T Study 1) and external contemporaneous controls (CMH and DPV).
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 500
(Inclusion criteria includes all youth with new onset T1D seen in the Stanford/Lucile Packard Children's Hospital ages 6 months-21 years of age. We intend to include all possible patients with the goal of maximizing generalizability of the results and 4T program. (NOTE: We will include children and families who speak all languages using the Stanford interpreter services so as to have the greatest generalizability of the research. Questionnaires will only be given to English and Spanish speakers.)
- All individuals within one month of T1D diagnosis seen at the Stanford Children's Diabetes Clinic
- Individuals who plan to receive follow up care at the Stanford Children's Diabetes Clinic
- Individuals who agree to CGM data integration into the EMR for remote monitoring
- Age: six months to < 21 years of age
- Patient or guardian must own and operate an Apple compatible device (e.g., iPhone or iPod Touch) to allow for Dexcom app and Apple HealthKit integration and transmission to the hospital server-based remote monitoring system and EHR.
Dr Prahalad's LPCH Auxiliary Fund grant (in addition to the R18) has resources to support iPod Touch purchase for participants who do not have these.
o For the Exercise Ancillary study: 11 to < 21 years of age (the activity tracker is not validated for younger children) English and Spanish-Speaking (Study 2)
- Diabetes diagnosis other than T1D
- Diagnosis of diabetes > one month prior to initial visit
- Individuals with the intention of obtaining diabetes care at another clinic
- Individuals who do not consent to CGM use, CGM data integration, remote monitoring
- Individuals > 21 years of age
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description T1D Patients 4T Education and Care Participants will wear a Continuous Glucose Monitor (CGM) with remote data monitoring
- Primary Outcome Measures
Name Time Method Change in rise of HbA1c Baseline, 6 months and 12 months post-diagnosis Rise in HbA1c (a measure of blood sugar levels over the previous 3 months) as a measurement of the effect of 4T education and care. Collected through a blood sample.
- Secondary Outcome Measures
Name Time Method Change in education exposure to safe exercise strategies Baseline, 3, 6, and 9 months Percentage of participants attending at least one telehealth session and a measure of education exposure to safe exercise strategies
Change Diabetes Distress Scale Baseline, 3, 6, 9 and 12 months This measure is widely used to capture the psychological distress experienced in relation to diabetes, and is reported by participants.
Score Range: 0-4 Interpretation: Higher scores indicates higher distress, a worse outcome
1. Not a Problem
2. A Slight Problem
3. A Moderate Problem
4. Somewhat Serious Problem
5. A Serious Problem
6. A Very Serious ProblemChange in Diabetes Technology Attitude Scale Baseline, 3, 6, 9 and 12 months This measure has questions on attitudes and use of various general technologies (e.g., smartphone) and diabetes devices, and is reported by participants.
Tool lists statement and participants reports how much they agree with the statement.
1 2 3 4 5 Strongly disagree Disagree Neutral Agree Strongly agreeChange in Promise Global Health Scale Baseline, 3, 6, 9 and 12 months This measure is widely used to capture general and overall health, and is reported by participants.
PROMISE GLOBAL HEALTH SCALES
5, Excellent \| 4, Very Good \| 3, Good \| 2, Fair \| 1, PoorChange in Physical Activity, Youth Physical Activity Questionnaire (Y-PAQ) Baseline, 3, 6 and 9 months Youth Physical Activity Questionnaire (Y-PAQ) is a measure used to determine overall physical activity in the last 7 days, and is reported by participants.
Score Range: 1 to 3. Interpretation: Higher scores indicate higher levels of physical activity, a better outcome.Change in participant Hypoglycemic Fear Scale Baseline, 3, 6 and 9 months People with diabetes worry about hypoglycemia. Hypoglycemic Fear Survey (HFS-II) measure captures those worries and is reported by participants.
Score Range: 0-4 Interpretation: Higher scores indicates higher levels of stress, a worse outcomeChange in CGM Benefits and Burden Scale Baseline, 3, 6, 9 and 12 months This tool measures the benefits and burden of Continuous Glucose Monitor (CGM) device use, and is reported by participants.
PERCEIVED BENEFITS OF CGM SCALE (BenCGM):
Below is a list of things people might think are good about wearing a CGM.
5 - Strongly agree 4 -Agree 3 - Neutral 2 - Disagree
1 - Strongly disagreeChange in Parental Diabetes Distress Scale Baseline, 3, 6, 9 and 12 months The Parental Diabetes Distress Scale (PARENT-DDS) measure is widely used to capture the psychological distress experienced by parents in relation to diabetes, and is reported by participants.
Score Range: 0-4 Interpretation: Higher scores indicates higher distress, a worse outcome
1. Not a Problem
2. A Slight Problem
3. A Moderate Problem
4. Somewhat Serious Problem
5. A Serious Problem
6. A Very Serious ProblemChange in Physical Activity, International Physical Activity Questionnaire (IPAQ) Baseline, 3, 6 and 9 months International Physical Activity Questionnaire (IPAQ) asks about physical activity and sedentary behavior in the last 7 days, and is reported by participants.
Score Range: 1 to 3. Interpretation: Higher scores indicate higher levels of physical activity, a better outcome.Change in parent Hypoglycemic Fear Scale Baseline, 3, 6 and 9 months Parents of children with diabetes worry about hypoglycemia. Hypoglycemic Fear Survey (HFS-P) measure captures those worries and is reported by parents of participants.
Score Range: 0-4 Interpretation: Higher scores indicates higher levels of stress, a worse outcomeChange in Self-Efficacy for Exercise Scale Baseline, 3, 6, and 9 months Self-Efficacy for Exercise (SEE) Scale measures how confident people are in their ability to overcome barriers to exercise.
Total scale is calculated by summing the responses to each question. The scale has a range of total scores from 0-90. A higher score indicates higher self-efficacy for exercise.
Trial Locations
- Locations (1)
Franziska Katherine Bishop
🇺🇸Steamboat Springs, Colorado, United States